Conditions: Chronic Obstructive Pulmonary Disease (COPD)
Keywords: COPD tolerability inhalation
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 65
Healthy volunteers: no

Brief summary:
The purpose of this study is to see if treatment with AZD4818 for four weeks is tolerable, safe and effective in treating COPD and, if so, how it compares with placebo.

Detailed description:

Arms:
arm 1: AZD4818 arm 2: Placebo

Interventions: intervention 1: AZD4818 intervention 2: Placebo
Intervention descriptions: intervention 1: Dry Powder, inhalation, b.i.d., 4 weeks intervention 2: None

Protocol document: